Expert Outlook: Moodys Through The Eyes Of 11 Analysts

Dec 20, 2024 · Analysts have set 12-month price targets for Moodys, revealing an average target of $509.36, a high estimate of $565.00, and a low estimate of $459.00.

$509.36
OFF

Expert Outlook: Moodys Through The Eyes Of 11 Analysts

2 weeks from now

Dec 20, 2024 · Analysts have set 12-month price targets for Moodys, revealing an average target of $509.36, a high estimate of $565.00, and a low estimate of $459.00.

nasdaq.com

$18.33
OFF

The Analyst Verdict: NOV In The Eyes Of 9 Experts - Nasdaq

2 weeks from now

15 hours ago · The 12-month price targets, analyzed by analysts, offer insights with an average target of $18.33, a high estimate of $24.00, and a low estimate of $12.00.

nasdaq.com

$83.75
OFF

Expert Outlook: Citigroup Through The Eyes Of 12 Analysts

2 weeks from now

Jan 3, 2025 · The 12-month price targets, analyzed by analysts, offer insights with an average target of $83.75, a high estimate of $107.00, and a low estimate of $64.00.

nasdaq.com

83%
OFF

Expert Outlook: Citigroup Through The Eyes Of 12 Analysts

2 weeks from now

Jan 3, 2025 · The 12-month price targets, analyzed by analysts, offer insights with an average target of $83.75, a high estimate of $107.00, and a low estimate of $64.00. Observing a 7.83% …

sahmcapital.com

$144.69
OFF

Expert Outlook: EOG Resources Through The Eyes Of 16 Analysts

2 weeks from now

Oct 16, 2024 · Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $144.69, along with a high estimate of $167.00 and a low …

nasdaq.com

$17.05
OFF

Expert Outlook: Sunrun Through The Eyes Of 15 Analysts

2 weeks from now

5 days ago · In the assessment of 12-month price targets, analysts unveil insights for Sunrun, presenting an average target of $17.05, a high estimate of $30.00, and a low estimate of $7.78.

nasdaq.com

$100.18
OFF

Expert Outlook: Ultragenyx Pharmaceutical Through The Eyes Of …

2 weeks from now

Dec 20, 2024 · The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $100.18, a high estimate of $121.00, and a low estimate of $73.00.

nasdaq.com

$227.57
OFF

Expert Outlook: ResMed Through The Eyes Of 7 Analysts

2 weeks from now

Sep 24, 2024 · Analysts have recently evaluated ResMed and provided 12-month price targets. The average target is $227.57, accompanied by a high estimate of $280.00 and a low estimate …

nasdaq.com